argus

Zydus Lifesciences Limited

NSE: ZYDUSLIFEINE010B010271,16,952 Cr

Timeline

Time (IST)TypeMEventSrc
19 May, 02:19 pmZydus Lifesciences Limited has informed the Exchange about Investor Presentationnse
19 May, 02:18 pmZydus Lifesciences Ltd - 532321 - Record Date For Dividend July 24, 2026bse
19 May, 02:15 pmZydus Lifesciences Limited has informed the Exchange regarding Change in Director(s) of the company.nse
19 May, 02:15 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
19 May, 02:14 pmZydus Lifesciences Ltd - 532321 - Corporate Action-Buy backbse
19 May, 02:13 pmZydus Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2026.nse
19 May, 02:12 pmZydus Lifesciences Ltd - 532321 - Corporate Action-Board approves Dividendbse
19 May, 02:11 pmZydus Lifesciences Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2026, recommended Final Dividend of Rs. 1.00 per equity share.nse
19 May, 02:10 pmZydus Lifesciences Ltd - 532321 - Board Meeting Outcome for Audited Financial Results For The Quarter / Year Ended On March 31, 2026bse
19 May, 02:09 pmZydus Lifesciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
19 May, 02:07 pmZydus Lifesciences Ltd - 532321 - Audited Financial Results For The Quarter / Year Ended On March 31, 2026bse
15 May, 11:25 amZydus Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
13 May, 08:59 pmZydus Lifesciences Limited has informed the Exchange about General Updatesnse
13 May, 08:37 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Acquisitionbse
13 May, 05:22 pmZydus Lifesciences Ltd - 532321 - Receipt Of Demand Order-In-Appeal From Appellate Authority, Central Goods And Services Tax Appeals Commissionerate, Chandigarhbse
13 May, 05:18 pmZydus Lifesciences Limited has informed the Exchange about General Updatesnse
13 May, 03:55 pmZydus Lifesciences Ltd - 532321 - Update on board meetingbse
13 May, 10:19 amZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Cessationbse
13 May, 10:14 amZydus Lifesciences Limited has informed the Exchange regarding Cessation of Mr Apurva S. Diwanji as Non- Executive Independent Director of the company w.e.f. May 12, 2026.nse
08 May, 04:08 pmZydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter / Year Ended On March 31, 2026bse
06 May, 11:06 amZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
06 May, 11:03 amZydus Lifesciences Limited has informed the Exchange regarding a press release dated May 06, 2026, titled "USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad".nse
05 May, 09:46 amZydus Lifesciences Ltd - 532321 - Receipt Of Demand Order-In-Original From Deputy Commissioner Of CGST & Central Excise, Ahmedabad North Commissioneratebse
05 May, 09:41 amZydus Lifesciences Limited has informed the Exchange about General Updatesnse
01 May, 01:03 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Acquisitionbse
01 May, 01:01 pmZydus Lifesciences Limited has informed the Exchange about General Updatesnse
01 May, 12:58 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Acquisitionbse
01 May, 12:55 pmZydus Lifesciences Limited has informed the Exchange about General Updatesnse
30 Apr, 11:28 amZydus Lifesciences Ltd - 532321 - Incorporation Of A Wholly Owned Subsidiary In The United States Of Americabse
30 Apr, 11:25 amZydus Lifesciences Limited has informed the Exchange about General Updatesnse
25 Apr, 12:52 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
25 Apr, 12:49 pmZydus Lifesciences Limited has informed the Exchange regarding a press release dated April 25, 2026, titled "Zydus receives approval from DCGI to initiate Phase III trials of Zintrodiazine, a novel anti-malarial candidate".nse
16 Apr, 12:51 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
16 Apr, 12:47 pmZydus Lifesciences Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Zydus receives EIR for oncology injectable manufacturing facility in SEZ1, Ahmedabad".nse
16 Apr, 09:38 amZydus Lifesciences Limited has informed the Exchange about General Updatesnse
15 Apr, 10:31 pmZydus Lifesciences Ltd - 532321 - Update On GST Orderbse
10 Apr, 11:41 amZydus Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
10 Apr, 09:46 amZydus Lifesciences Ltd - 532321 - ESG Ratingbse
10 Apr, 09:40 amZydus Lifesciences Limited has informed the Exchange about General Updatesnse
08 Apr, 09:47 amZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
08 Apr, 09:44 amZydus Lifesciences Limited has informed the Exchange regarding a press release dated April 08, 2026, titled "Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg".nse
07 Apr, 03:05 pmZydus Lifesciences Ltd - 532321 - Intimation Of Drop In GST Demandbse
06 Apr, 06:10 pmZydus Lifesciences Ltd - 532321 - Intimation Of Drop In GST Demandbse
06 Apr, 06:08 pmZydus Lifesciences Limited has informed the Exchange about General Updatesnse
01 Apr, 10:49 amZydus Lifesciences Ltd - 532321 - Receipt Of Demand Order-In-Original From Assistant Commissioner, Central Goods And Services Tax, Division-Ambalabse
01 Apr, 10:45 amZydus Lifesciences Limited has informed the Exchange about General Updatesnse
31 Mar, 04:34 pmZydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Change in Managementbse
31 Mar, 04:32 pmZydus Lifesciences Limited has informed the Exchange about change in Managementnse
27 Mar, 09:51 amZydus Lifesciences Limited has informed the Exchange regarding 'Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015'.nse
25 Mar, 04:24 pmZydus Lifesciences Ltd - 532321 - Receipt Of Demand Order-In-Original From Assistant Commissioner Of State Tax, Gujarat.bse